Loading...

Zimmer Biomet Holdings, Inc.

ZBHNYSE
Healthcare
Medical - Devices
$92.40
$1.78(1.96%)

Zimmer Biomet Holdings, Inc. (ZBH) Stock Overview

Explore Zimmer Biomet Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.9/100

Key Financials

Market Cap18.3B
P/E Ratio20.13
EPS (TTM)$4.50
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$90.32
1 Month$87.39
3 Months$83.46
1 Year Target$96.51

ZBH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zimmer Biomet Holdings, Inc. (ZBH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $96.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.13 and a market capitalization of 18.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;